Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-05-16

Clinical Trial Update: Effects of Esketamine on the Incidence of Postoperative Delirium and Postoperative Sleep Disturbance in Elderly Patients After Major Non-cardiac Surgery [NA]

View source ↗

Summary

This entry reports the withdrawal of a clinical trial examining esketamine for reducing postoperative delirium and sleep disturbance in elderly patients after m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: RenJi Hospital | Conditions: Postoperative Delirium (POD), Postoperative Sleep Disturbance | NA | Status: WITHDRAWN